EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Traumatic brain injury, changes in plasma amyloid, tau, and neurodegenerative biomarkers, and dementia risk

Alexa E Walter, James R Pike, Josef Coresh, Ramon Diaz-Arrastia, David Menon, Rebecca F Gottesman, Priya Palta, Andrea L C Schneider

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Alexa E Walter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, tau Proteins, Amyloid beta-Peptides, Dementia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Long‐term trajectories of plasma biomarkers in relation to incident traumatic brain injury (TBI) and whether TBI modifies associations of biomarkers with dementia risk are unknown. METHODS One thousand fifty Atherosclerosis Risk in Communities (ARIC) study participants without prior TBI had amyloid beta (Aβ 42 /Aβ 40 ), phosphorylated‐tau181 (pTau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) measured from plasma collected in 1993 to 1995, 2011 to 2013, and 2016 to 2019. Linear mixed‐effects models estimated biomarker trajectories associated with TBI and Cox proportional hazards models determined if TBI modified associations of biomarkers with incident dementia through December 31, 2020. RESULTS After the median time of incident TBI, Aβ 42 /Aβ 40 levels remained lower for 9.3 years, and pTau181, NfL, and GFAP remained elevated for 8.5, >13.8, and 12.7 years, respectively. There was evidence of additive interaction by TBI in associations of log 2 NfL with incident dementia ( p = 0.024). DISCUSSION TBI alters trajectories of plasma biomarkers of neurodegeneration for approximately a decade after the injury and modifies associations of NfL with dementia risk. Highlights Our findings provide evidence that TBI fundamentally alters trajectories of plasma biomarkers of AD‐related pathology, neuronal degeneration, and astrogliosis for approximately a decade after the injury. Further, our findings also suggest that an incident TBI event adds to and interacts with ongoing neurodegenerative processes to increase the risk of later life dementia. These results suggest that the pathologic processes underlying post‐TBI dementia are heterogeneous, that individuals with preclinical changes in neurodegenerative biomarkers may be more susceptible to TBI (i.e., that associations are bidirectional), or a combination thereof.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Injuries, Traumatictau ProteinsAmyloid beta-PeptidesDementiaHumansBiomarkersMaleFemaleAgedNeurofilament ProteinsGlial Fibrillary Acidic ProteinMiddle AgedRisk Factors

Stichwörter der Autor:innen

Cohort studyTBIdementiaplasma biomarkerstraumatic brain injury

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesNeurofilament ProteinsGlial Fibrillary Acidic Proteinneurofilament protein L

Autor:innen und Institutionen

  • Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Optimal Aging Institute, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Anaesthesia, University of Cambridge, Cambridge, UK.
  • National Institute of Neurological Disorders and Stroke, Intramural Research Program, Bethesda, Maryland, USA.
  • Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Förderung

  • NIH HHS
  • NINDS NIH HHS
  • NHLBI NIH HHS
  • Department of Defense
  • National Institutes of Health/National Institutes on Aging
  • NIDCD NIH HHS
  • NIA NIH HHS
  • National Institute for Health and Care Research

Zitieren

APA

Walter, A. E., Pike, J. R., Coresh, J., Diaz-Arrastia, R., Menon, D., Gottesman, R. F., Palta, P., & Schneider, A. L. C. (2025). Traumatic brain injury, changes in plasma amyloid, tau, and neurodegenerative biomarkers, and dementia risk. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70611

Vancouver

Walter AE, Pike JR, Coresh J, Diaz-Arrastia R, Menon D, Gottesman RF, et al. Traumatic brain injury, changes in plasma amyloid, tau, and neurodegenerative biomarkers, and dementia risk. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70611

BibTeX
@article{Walter2025,
  author = {Walter, Alexa E and Pike, James R and Coresh, Josef and Diaz-Arrastia, Ramon and Menon, David and Gottesman, Rebecca F and Palta, Priya and Schneider, Andrea L C},
  title = {Traumatic brain injury, changes in plasma amyloid, tau, and neurodegenerative biomarkers, and dementia risk},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70611}
}
Kostenlos starten →